	Mapping therapy-responsive immune ecotypes in clear cell renal cell carcinoma through integrative omics. Front Immunol Zhang Z, He L, Chen B, Zhang H. PMID: 42529102 [PubMed - indexed for MEDLINE]
	PSMA-targeted radioligand therapy in advanced prostate cancer: a narrative review of ^177Lu-PSMA, emerging ^225Ac-PSMA strategies, and therapeutic sequencing. Oncol Rev Gierulska N, Jankowska N, Kwiatkowska A, Kuchno P, , Szklener K, Ko, Skórzewska M. PMID: 42529062 [PubMed]
	Awareness, risk perception, and attitudes toward prostate cancer detection and MRI among Armenian men. Front Public Health Shalunc NN, Gaboyan SS, Matinyan NG, Mnatsakanyan TS, Hovhannisyan MG, Ergas IJ. PMID: 42529047 [PubMed - indexed for MEDLINE]
	Case Report: Immune checkpoint inhibitor-induced IgG4-related disease mimicking renal metastatic progression: successful steroid-sparing management with rituximab. Front Immunol Bonatto ME, Dvo, Kollár M, Girsa D, Pr, Forejtová , Mann H, Vencovský J, Pavelka K, . PMID: 42528919 [PubMed - indexed for MEDLINE]
	Per- and Polyfluoroalkyl Substances Exposure in New Jersey Prostate Cancer Survivors: A Pilot Biomonitoring Study. medRxiv Joseph SA, Opara C, Shanahan MR, Varga J, Falcon J, Ibanga U, Venkatraman S, Perlstein M, Jang TL, Golombos D, Ghodoussipour S, Fan T, O'Leary S, Graber JM, Hart JE, Barrett ES, Bandera EV, Iyer HS. PMID: 42528551 [PubMed]
	Trends in the Adoption of MRI Associated Biopsy for Active Surveillance Within the First Year After Localized Prostate Cancer Diagnosis: A SEER-Medicare Cohort Study. Cancer Med Liu Y, Polychronopoulou E, Jackson J, Williams S, Kuo YF. PMID: 42528154 [PubMed - indexed for MEDLINE]
	Prognostic Factor Analysis and Nomogram Development in Castration-Resistant Prostate Cancer with Visceral Metastases for Future Radionuclide Therapy Selection. Cancer Biother Radiopharm Xu P, Lin X, Zhu Y, Chen J, Yang B. PMID: 42528049 [PubMed - as supplied by publisher]
	DLL3-Targeted Strategies in Advanced Prostate Cancer: Current Evidence and Future Perspectives. Drugs Pecoraro G, De Giorgi A, Montelatici G, Salfi G, Lin HM, Turco F, Taha T, Beltran H, de Bono J, Aggarwal RR, von Amsberg G, Joerger M, Imbimbo M, Colombo I, Gillessen S, Pedrani M. PMID: 42527846 [PubMed - as supplied by publisher]
	Pembrolizumab Plus Lenvatinib in Metastatic Renal Cell Carcinoma: Real-world Prognostic Factors. Anticancer Res Yamashita S, Yamasaki T, Ueda K, Tomida R, Toyoda S, Iwamoto H, Miyake M, Tomisaki I, Morizane S, Kohjimoto Y. PMID: 42527074 [PubMed - indexed for MEDLINE]
	Differences in Unmet Needs Between Older and Younger Patients With Advanced Renal Cell Carcinoma. Anticancer Res Negishi T, Furubayashi N, Kojima T, Nakano Y, Kataoka A, Nakamura M. PMID: 42527058 [PubMed - indexed for MEDLINE]
	Effectiveness and Safety of Enfortumab Vedotin Plus Pembrolizumab for Patients Aged 80 Years and Older With Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study. Anticancer Res Kobari Y, Nakajima N, Saito A, Katsurayama N, Inakawa T, Kubota S, Nemoto Y, Nakamura K, Nishimura K, Ishihara H, Yagisawa T, Fukuda H, Yoshida K, Iizuka J, Shimmura H, Hashimoto Y, Kondo T, Kobayashi H, Takagi T. PMID: 42527056 [PubMed - indexed for MEDLINE]
	Can Engagement aid in design and accrual on Clinical Trials? Observations from COMPPARE - A Prospective Comparison of Outcomes with Proton and Photon Radiation in Prostate Cancer. Int J Radiat Oncol Biol Phys Mendenhall NP, Bryant CM, Katz AJ, Chen R, DeWees T, Hobkirk J, Bremer C, Grammel LW, Griggs C, Marckini R, Nelson R, Simons V, Odedina FT, Vapiwala N, Deville C Jr, Crisp AM, Morris CG. PMID: 42526648 [PubMed - as supplied by publisher]
	Precision targeting in prostate cancer: Mechanistic drivers and the evolving clinical pipeline. Drug Discov Today Nathe P, Singh Y, Ratre P, Kulkarni S. PMID: 42526626 [PubMed - as supplied by publisher]
	Comparison of 5-aminolevulinic acid-induced hypotension of extending the oral administration period during photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancer. Photodiagnosis Photodyn Ther Fukuhara H, Shigehisa R, Yamamoto S, Fukata S, Saito K, Kamiya A, Shibanaka Y, Koga K, Inoue K. PMID: 42526612 [PubMed - as supplied by publisher]
	Expression of PCAT19, miR-195, ITGA6, and E-cadherin in prostate cancer: a preliminary tissue-based study. Cancer Treat Res Commun Hussein S, Zahra M, Shalaby AA, Salama MFA, Sameh R, Waley AB, Shawky SA, Aboafya ZI, Matar I, Amgd M, Algazeery A. PMID: 42526156 [PubMed - as supplied by publisher]
	Abstract: Racial and Socioeconomic Disparities in Inpatient Outcomes Among Older Adults Hospitalized With Prostate Cancer: Insights from the National Inpatient Sample (2020-2022). S D Med Tahir H, Anwar MZ, Waheed RI, Farooqi M, Roberts M, Khan D. PMID: 42525991 [PubMed - indexed for MEDLINE]
	Robotic-assisted intracorporeal radical cystectomy with modified ileal conduit reduces ureteroileal anastomotic stenosis risk: a comparative study with laparoscopic surgery. Ann Med Gu T, Gunelli R, Chen T, Wang C, Pan Y, Yu Q, Li J. PMID: 42525819 [PubMed - indexed for MEDLINE]
	Intra-corporeal robot-assisted versus open radical cystectomy: a meta-analysis. World J Urol Gan L, Wu J, Li Z, Cao H, Wang H, Li Y, Sun Z, Wang W. PMID: 42525253 [PubMed - indexed for MEDLINE]
	Global Dual Incidence-Mortality Patterns of Prostate Cancer Across SDI Regions, 1990-2021: A Cross-Sectional Study Based on Global Burden of Disease 2021. Health Sci Rep Ma Z, Wang C, Zhang Q, Lu Z, Chen D, Zhang X, Wang Y. PMID: 42524350 [PubMed]
	Programmed cell death mechanisms of traditional plant medicine in prostate cancer therapy. Front Immunol Zhang Y, Qin S, Wang Y, Xu Y, Zhu Y. PMID: 42523794 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 180398

Page 1 of 9020



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy